Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Commentary | 2023
Hallucinogens/psychedelics, Policy/Regulatory
We aimed to assess the effect of methadone on non-opioid substance use compared to buprenorphine/naloxone (BUP/NX), to explore whether non-opioid substance use is associated with opioid use and ret
Original research | 2023
Substitution/OAT
Assess the preliminary impact of Brave Technology Co-op’s overdose detection devices that have been implemented in housing, medical, social service facilities, and several private settings in North
Original research | 2023
Digital health, Overdose
We conducted a retrospective cohort study of EMS patients who survived a prior opioid overdose in 2019-2021 in King County, Washington.
Original research | 2023
Overdose, Mortality, About PWUD
Report | 2023
Policy/Regulatory, Safer supply, Advocacy
Manuel | 2023
site de consommation supervisée / centre de prévention des surdoses, la politique / le cadre de réglementation, les drogues illégales
Guide or handbook | 2023
SCS/OPS, Policy/Regulatory, Illegal drugs
We evaluated the effectiveness of a Two-Eyed Seeing approach in a four-week harm reduction residential treatment programme for clients with a history of substance use disorder (SUD) and intergenera
Original research | 2023
Harm reduction, Wrap-around services, About PWUD, Indigenous
We evaluated the implementation and outcomes of a MOUD program offered by 2 of the first jails nationwide to provide access to medications to treat opioid use disorder (MOUD, ie, buprenorphine, met
Original research | 2023
Legal system/law enforcement, Substitution/OAT
Report | 2023
Safer supply, Outcomes, Evidence base, Stimulants
Patients in treatment with medications for opioid use disorder (MOUD) often report use of other substances in addition to opioids.
Original research | 2023
Transitions in care/treatment, About PWUD, Outcomes
The objectives were to identify sociodemographic, self-reported health and mental health, patterns of service utilization (service type and frequency of visits) among youths with different levels o
Original research | 2023
About PWUD, Youth, Mental health
In this scoping review, we synthesize the existing literature on patient transition interventions, and form an initial typology of reported strategies.
Scoping review | 2023
Transitions in care/treatment, Hospitals, Barriers and enablers, About prescribers
This meta-analysis pooled effect estimates of outcomes from placebo-controlled randomized clinical trials (RCTs) examining bupropion efficacy and safety for amphetamine-type stimulant use disorder
Lit review | 2023
Stimulants
This study aimed to examine the association of comorbid cocaine, alcohol (binge drinking), and sedative use with mortality among hospitalized patients with opioid use disorder (OUD).
Original research | 2023
Mortality, Hospitals, About PWUD, Outcomes, Transitions in care/treatment
Research on values is gaining in popularity within drug policy scholarship.
Original research | 2023
Policy/Regulatory, About PWUD
The current study aims to investigate how patients experience on-site application and derive strategies to enhance the acceptability and effectiveness of iOAT-delivery.
Original research | 2023
Substitution/OAT, Injecting drugs, About PWUD, Barriers and enablers
This article explores the conceptualisation of retention in treatment for opioid use disorder (OUD) using long-acting injectable buprenorphine (LAIB) as a journey.
Original research | 2023
Substitution/OAT, Transitions in care/treatment, About PWUD
Webpage | 2023
Peer/PWLLE program involvement, Social services, Barriers and enablers
In this paper, we report on data from a participatory, qualitative research project focused on four intersecting communities often engaged in peer research: mental health service user/consumer/surv
Original research | 2023
Peer/PWLLE program involvement
